BOVINE RESPIRATORY DISEASE TREATMENT MARKET ANALYSIS
Increasing development of innovative treatment measures for bovine respiratory disease to boost market growth
Key players in bovine respiratory disease treatment market include Zoetis Inc., Bayer AG, Merck & Co., Inc., Virbac Group, Boehringer Ingelheim GmbH, Elanco, Vetoquinol, and Bimeda Animal Health. In 2015, Bayer launched Immunostimulant Zelnate, which effectively reduces bovine respiratory disease (BRD) associated mortality and lung lesions in cattle. Zelnate is the first cytosine-phosphate-guanine (CpG) motif-based immunostimulant authorized by the U.S. Department of Agriculture.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
